APA (7th ed.) Citation

E, A., EK, A., O, A., DM, W., & SM, R. (2024). The 5HT2b Receptor in Alzheimer's Disease: Increased Levels in Patient Brains and Antagonist Attenuation of Amyloid and Tau Induced Dysfunction. Journal of Alzheimer's disease : JAD, 98(4), 1349. https://doi.org/10.3233/JAD-240063

Chicago Style (17th ed.) Citation

E, Acquarone, Argyrousi EK, Arancio O, Watterson DM, and Roy SM. "The 5HT2b Receptor in Alzheimer's Disease: Increased Levels in Patient Brains and Antagonist Attenuation of Amyloid and Tau Induced Dysfunction." Journal of Alzheimer's Disease : JAD 98, no. 4 (2024): 1349. https://doi.org/10.3233/JAD-240063.

MLA (9th ed.) Citation

E, Acquarone, et al. "The 5HT2b Receptor in Alzheimer's Disease: Increased Levels in Patient Brains and Antagonist Attenuation of Amyloid and Tau Induced Dysfunction." Journal of Alzheimer's Disease : JAD, vol. 98, no. 4, 2024, p. 1349, https://doi.org/10.3233/JAD-240063.